๐ฆ Middle East Respiratory Syndrome (MERS-CoV):
Fever may be absent in infants, elderly, immunosuppressed, or those on antipyretics โ maintain suspicion in at-risk cases.
โน๏ธ About
- Viral respiratory illness caused by MERS coronavirus (MERS-CoV).
- First identified in Saudi Arabia (2012), later reported in the Middle East, Asia, Europe, USA.
- ๐ช Camels = natural reservoir; human-to-human spread in healthcare settings.
๐งฌ Aetiology
- Novel coronavirus strain causing severe lower respiratory disease.
- Incubation: 2โ14 days (median ~5โ6).
- Transmission: droplets, direct contact, contaminated surfaces.
๐ค Clinical Features
- Respiratory: Fever, cough, dyspnoea โ pneumonia, ARDS.
- GI: Diarrhoea, nausea, vomiting, abdominal pain.
- Severe illness: ARDS, septic shock, multi-organ failure; worse with diabetes, CKD, immunosuppression.
- Atypical: Afebrile presentation in high-risk groups.
๐งช Investigations
- ๐ฉธ Bloods: U&E (AKI risk), LFTs, FBC.
- ๐จ ABG: Assess hypoxaemia/respiratory failure.
- ๐งซ PCR: Nasopharyngeal, sputum, or BAL = diagnostic gold standard.
- ๐ฉป CXR/CT: Bilateral pneumonia, ARDS, ground-glass opacities.
๐ก๏ธ Prevention
- ๐ซ Avoid raw camel milk/urine & undercooked camel meat.
- ๐ฅ Strict infection control: standard + contact + airborne precautions.
- ๐ท PPE: N95 mask, gown, gloves, eye protection for healthcare workers.
- ๐ช Isolation: suspected/confirmed patients in negative-pressure rooms if available.
๐ Management
- Supportive: ABCs, Oโ, IV fluids, vasopressors if shock.
- Advanced: ITU/HDU for mechanical ventilation, renal replacement if needed.
- No licensed antivirals; investigational drugs under study.
- ๐งด Infection control = critical to prevent outbreaks (PPE, hand hygiene, surface disinfection).
- ๐ Mild disease: home isolation until recovery.
๐ References